Rx Price Restraint Hits McKesson; Wholesaler Sees Delay, Not Policy Change

Pharmaceutical price increases remain a critical component of manufacturers' commercial strategies, McKesson CEO John Hammergren assured analysts during the Thomas Weisel Partners Healthcare Conference in Boston Sept. 9